“What’s New in Addiction Medicine?” lecture series

Dear colleagues,

On behalf of the Urban Health Research Initiative, we would like to invite you to join us on Thursday, January 30th at the fourth edition of the “What’s New in Addiction Medicine?” lecture series.  This (free) event features a presentation by St. Paul’s Hospital/Goldcorp Addiction Medicine Fellow, Dr. John Koehn, between 12-12:55pm.  Dr. Koehn’s talk is entitled “Treating Alcohol Withdrawal: Alternatives to Benzodiazepines” and will be hosted at St. Paul’s Hospital in the Hurlburt Auditorium where a light lunch will be provided.

We strongly encourage guests to RSVP as soon as possible to ensure sufficient food and space.  (Please note that you will not need to bring registration tickets to the event.)

To RSVP, please click here.

If you have any questions about event logistics, contact Cameron Collins (ccollins@cfenet.ubc.ca).


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below